These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19731036)

  • 21. Low frequency ultrasound and UV-C for elimination of pathogens in recirculating aquaculture systems.
    Bazyar Lakeh AA; Kloas W; Jung R; Ariav R; Knopf K
    Ultrason Sonochem; 2013 Sep; 20(5):1211-6. PubMed ID: 23434531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Release profile of compound liposomes entrapped with vincristine sulfate and mitoxantrone chlorhydric acid in vitro and their distribution in mice].
    Chen T; Hou SX; Wang YY; Zhang WS; Chen DH
    Yao Xue Xue Bao; 2006 Dec; 41(12):1170-5. PubMed ID: 17290615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
    Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
    Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid membrane composition influences drug release from dioleoylphosphatidylethanolamine-based liposomes on exposure to ultrasound.
    Evjen TJ; Nilssen EA; Fowler RA; Røgnvaldsson S; Brandl M; Fossheim SL
    Int J Pharm; 2011 Mar; 406(1-2):114-6. PubMed ID: 21185927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model.
    Harrington KJ; Rowlinson-Busza G; Syrigos KN; Vile RG; Uster PS; Peters AM; Stewart JS
    Clin Cancer Res; 2000 Dec; 6(12):4939-49. PubMed ID: 11156255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of drug release from liposomal formulations in ocular fluid.
    Jafari MR; Jones AB; Hikal AH; Williamson JS; Wyandt CM
    Drug Deliv; 1998; 5(4):227-38. PubMed ID: 19569989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM; Mumbengegwi DR; Charrois GJ
    Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Higher liposomal membrane fluidity enhances the in vitro antitumor activity of folate-targeted liposomal mitoxantrone.
    Kawano K; Onose E; Hattori Y; Maitani Y
    Mol Pharm; 2009; 6(1):98-104. PubMed ID: 19072653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of frequency and power of ultrasound on the size reduction of liposome.
    Yamaguchi T; Nomura M; Matsuoka T; Koda S
    Chem Phys Lipids; 2009 Jul; 160(1):58-62. PubMed ID: 19397902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trigger release liposome systems: local and remote controlled delivery?
    Bibi S; Lattmann E; Mohammed AR; Perrie Y
    J Microencapsul; 2012; 29(3):262-76. PubMed ID: 22208705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chondroitin sulfate functionalized liposomes for solid tumor targeting.
    Bagari R; Bansal D; Gulbake A; Jain A; Soni V; Jain SK
    J Drug Target; 2011 May; 19(4):251-7. PubMed ID: 20545459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting drug release from liposomes.
    Lindner LH; Hossann M
    Curr Opin Drug Discov Devel; 2010 Jan; 13(1):111-23. PubMed ID: 20047152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor.
    Abu Lila AS; Doi Y; Nakamura K; Ishida T; Kiwada H
    J Control Release; 2010 Mar; 142(2):167-73. PubMed ID: 19861140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of vehicle on topical liposomal drug delivery: petrolatum bases.
    Foldvari M
    J Microencapsul; 1996; 13(5):589-600. PubMed ID: 8864995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of microwave radiation on the biophysical properties of liposomes.
    Gaber MH; Abd El Halim N; Khalil WA
    Bioelectromagnetics; 2005 Apr; 26(3):194-200. PubMed ID: 15768431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposome combined porous beta-TCP scaffold: preparation, characterization, and anti-biofilm activity.
    Zhu CT; Xu YQ; Shi J; Li J; Ding J
    Drug Deliv; 2010 Aug; 17(6):391-8. PubMed ID: 20429845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Light-triggered liposomal release: membrane permeabilization by photodynamic action.
    Pashkovskaya A; Kotova E; Zorlu Y; Dumoulin F; Ahsen V; Agapov I; Antonenko Y
    Langmuir; 2010 Apr; 26(8):5726-33. PubMed ID: 20000430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy.
    Chang HI; Yeh MK
    Int J Nanomedicine; 2012; 7():49-60. PubMed ID: 22275822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.